Geisinger Health System

Cape Urgent Care is the health provider. Cape Urgent Care is for medical conditions that are non-life threatening. Routine medical care is offered if you do not have a doctor, cannot be seen by your doctor, or are visiting from out of town. We care for children and adults, welcome walk-ins, and provide x-ray and lab testing. Sprains, scrapes, bruises, back injuries, or broken bones Lacerations, stitches Splinters, fishhooks Minor eye injuries or foreign bodies Nosebleeds Motor vehicle accidents (non-life or limb threatening) Workers Compensation injuries Colds, Flu, sore throats, fever, cough, ear aches, allergies Abdominal pains, urinary infections Skin abcesses or boils, rashes, insect bites, ingrown toenails Burns, including sunburn Joint pains, bursitis, tendonitis

Cernostics, Inc. is a diagnostics company based in Pittsburgh, Pennsylvania, specializing in cancer diagnostics and prognostics through a tissue systems biology approach. Founded in 2008, Cernostics develops the TissueCypher Barrett’s esophagus assay, which utilizes whole slide digital imaging technology to assess the risk for patients with Barrett’s esophagus, thereby reducing uncertainty in treatment decisions for gastroenterologists. The company's patent-protected TissueCypher platform analyzes whole slide digital images using multiplexed fluorescence, enhancing the accuracy of traditional tissue diagnostics by evaluating tumors as complex systems comprised of multiple cell types. Additionally, Cernostics operates a high-complexity clinical reference laboratory that supports biomarker discovery, validation, and clinical trial efforts, ultimately aiming to improve patient outcomes and reduce healthcare costs. The company has established a strategic collaboration with Deciphex Limited to further its capabilities in spatial biology and AI-driven image analytics.

Cernostics, Inc. is a diagnostics company based in Pittsburgh, Pennsylvania, specializing in cancer diagnostics and prognostics through a tissue systems biology approach. Founded in 2008, Cernostics develops the TissueCypher Barrett’s esophagus assay, which utilizes whole slide digital imaging technology to assess the risk for patients with Barrett’s esophagus, thereby reducing uncertainty in treatment decisions for gastroenterologists. The company's patent-protected TissueCypher platform analyzes whole slide digital images using multiplexed fluorescence, enhancing the accuracy of traditional tissue diagnostics by evaluating tumors as complex systems comprised of multiple cell types. Additionally, Cernostics operates a high-complexity clinical reference laboratory that supports biomarker discovery, validation, and clinical trial efforts, ultimately aiming to improve patient outcomes and reduce healthcare costs. The company has established a strategic collaboration with Deciphex Limited to further its capabilities in spatial biology and AI-driven image analytics.

Caresite Pharmacy Operator of retail drug store intended to delivers clinical and specialty pharmacy products and services. The company's retail drug store provides outpatient and institutional pharmacy services enabling patients and hospitals to get directions in complex environment of prescription medications and therapy through their trained professionals pharmacists.